What Was The Bite Of 83?

In the summer of 1983, a cluster of severe muscle injuries struck people in the United States, and it briefly looked like a new disease was spreading. It was not an infection. The “bite of 83” refers to a group of cases tied to an illness called eosinophilia-myalgia syndrome, or EMS, that was later linked to a specific dietary supplement. The name is a bit of a misnomer, because no bite was involved at all.

The story matters because it became one of the clearest examples in modern medicine of how a product sold as a health aid can cause serious harm, and how careful detective work by public health officials can trace a mysterious illness back to its source.

What Was The Bite Of 83?

The “bite of 83” is a nickname for a wave of cases of eosinophilia-myalgia syndrome that appeared in 1989, not 1983. The confusion likely comes from the way the phrase spread online, where dates and details often drift. The actual outbreak centered on a supplement called L-tryptophan, an amino acid sold in health food stores as a sleep aid and mood support product.

In late 1989, doctors in New Mexico began reporting patients with a strange combination of symptoms: severe muscle pain, weakness, and very high levels of a type of white blood cell called eosinophils. The condition was eventually named eosinophilia-myalgia syndrome. “Eosinophilia” refers to the elevated eosinophils. “Myalgia” means muscle pain. “Syndrome” means a collection of signs and symptoms that occur together.

Public health investigators traced the cases to L-tryptophan products, and the supplement was recalled. The number of cases declined sharply after the recall. The episode is remembered as a landmark in supplement safety and foodborne illness investigation.

What Is Eosinophilia-Myalgia Syndrome?

EMS is a rare inflammatory condition that affects the skin, muscles, and connective tissue. It is defined by three features occurring together: a blood eosinophil count above 1,000 cells per microliter, severe muscle pain that interferes with daily activity, and no other clear explanation for those findings.

Eosinophils are a type of immune cell that normally help fight parasites and play a role in allergic reactions. When they rise dramatically in the blood and migrate into tissues, they can cause damage. In EMS, the inflammation can affect the skin, causing a rash or thickening, and the muscles, causing pain and weakness. In severe cases, it can involve the nerves and internal organs.

The condition is not contagious. It does not spread from person to person. The cases clustered in time because many people were exposed to the same product, not because the illness itself was infectious.

What Caused The Bite Of 83 Outbreak?

The outbreak was linked to L-tryptophan supplements made by a single manufacturer in Japan and sold under many brand names. Investigators found that cases were strongly associated with products from that one company, rather than with L-tryptophan in general.

The exact contaminant was never confirmed with total certainty. The leading theory is that a change in the manufacturing process introduced an impurity, and that this impurity triggered the illness in susceptible people. Scientists identified several compounds in the suspect batches that were not present in other products, but proving which one caused EMS in humans was not possible with the tools of the time.

This is an important nuance. L-tryptophan itself is a normal amino acid found in protein foods like turkey, chicken, eggs, and cheese. The body uses it to make serotonin, a chemical involved in mood and sleep. Eating tryptophan in food has not been linked to EMS. The problem appeared to be specific to certain supplement batches, not to the amino acid as a natural dietary component.

What Were The Symptoms Of EMS?

The hallmark symptoms were severe muscle pain and weakness, often described as burning or aching, that came on over days to weeks. Many patients also had fatigue, skin changes, and swelling.

Common features reported in case series included:

• Severe muscle pain and tenderness, often worse in the arms and legs
• Muscle weakness that made routine tasks difficult
• Skin rash, thickening, or a feeling of tightness
• Fatigue and a general feeling of being unwell
• Joint pain and swelling in some cases
• Shortness of breath or nerve symptoms in more severe cases

Blood tests typically showed a high eosinophil count. Other tests might show elevated markers of inflammation or liver enzymes. Because the symptoms overlap with many other conditions, diagnosis depended on recognizing the pattern and asking about supplement use.

How Was The Outbreak Investigated And Stopped?

The investigation was a model of epidemiological detective work. State health departments and the Centers for Disease Control and Prevention collected case reports, interviewed patients, and compared what people with EMS had in common.

The key finding was a strong association with L-tryptophan supplements. Investigators then compared brands and manufacturers and found that cases clustered around products from one supplier. This pattern pointed to a problem with a specific manufacturing source rather than a widespread issue with the supplement category.

In November 1989, the U.S. Food and Drug Administration advised consumers to stop using L-tryptophan supplements, and a recall followed. New cases dropped quickly after the recall. The FDA later maintained restrictions on L-tryptophan supplements for years, though the supplement is now available again in the United States.

The episode led to lasting changes. It strengthened systems for tracking supplement-related illnesses and influenced how regulators and researchers think about the safety of dietary supplements, which are not held to the same pre-market testing standards as prescription drugs.

Is L-Tryptophan Safe Today?

L-tryptophan is available again as a supplement in the U.S. and is generally considered safe for most people at typical doses, based on decades of use since the outbreak. However, the evidence on long-term safety and effectiveness for most of the reasons people take it is limited.

It is worth being clear about what is and is not established. There is no strong evidence that L-tryptophan supplements reliably improve sleep or mood in the general population. Some small studies suggest possible effects, but results are mixed and the studies are generally short and small. The marketing claims often go well beyond what the research supports.

Anyone considering L-tryptophan should know that it can interact with certain medications, particularly antidepressants and other drugs that affect serotonin. Combining them can raise the risk of a rare but serious condition called serotonin syndrome. This is a real concern, not a theoretical one. People taking prescription medications should talk with a clinician before using L-tryptophan or any supplement that affects serotonin.

Because dietary supplements are regulated differently from drugs, the purity and content of products can vary. A supplement label does not guarantee what is actually in the bottle. This is a general limitation of the supplement market, not a claim that any specific current product is unsafe.

What Does The Bite Of 83 Teach Us About Supplement Safety?

The outbreak showed that a product sold as natural and health-promoting can cause serious harm. “Natural” does not mean risk-free. The source of the problem was not the amino acid itself but something introduced during manufacturing, which is a reminder that how a supplement is made matters as much as what it contains.

It also showed the value of public health surveillance. The illness was rare and its cause was not obvious. It took coordinated reporting and analysis to connect the dots. Without that work, cases might have continued and the link to supplements might have gone unrecognized.

For consumers, the practical takeaway is not to fear all supplements but to be skeptical of strong claims. A supplement that promises to fix sleep, mood, or pain with little supporting evidence deserves caution. Checking with a clinician, especially when taking other medications, is a reasonable step.

Was The Bite Of 83 A Real Bite?

No. The name is misleading. Nothing bit anyone. The phrase appears to be a distorted version of the EMS outbreak story, and the year in the nickname is wrong as well. The actual event happened in 1989.

The confusion may come from how health stories get reshaped as they spread online. A rare supplement-related illness became a catchy phrase, and the details blurred. The core facts remain: a contaminated supplement caused a serious outbreak, investigators traced it, and the product was recalled.